Systematic investigation of the relationships between 25 crystal structures containing the carbamazepine molecule or a close analogue: a case study of the XPac method

The concept of supramolecular constructs (CrystEngCom 2005, 7, 324) is used to compare 25 related crystal structures. This set is based on the carbamazepine (CBZ) molecule and contains four polymorphic modifications of CBZ, 19 multiple-component crystals and two close analogues of CBZ. Common zero- to three-dimensional structure fragments are identified and discussed. Two fragments of closely packed CBZ molecules, a stack and dimer, are identified as the dominating motifs. These are observed in 24 of the 25 structures. The close 2-D similarity relationship, based on the stack motif, between the triclinic and trigonal modifications CBZ is a particularily intriguing case. In contrast, the other two polymorphs of CBZ contain the dimer motif and they exhibit a 1-D similarity. This study demonstrates that the XPac method is a suitable method for the investigation of large sets of related crystal structures. A graphical method for the visualisation of complex similarity relationships is proposed. The results of this work highlight the great importance that the molecular shape plays in the assembly of molecules in the solid state even in such cases where hydrogen bonds are present.

[1]  L. Fábián,et al.  Dipole-induced polymorphs of trans-2-hydroxycycloheptanecarboxylic acid with virtually the same unit cell. , 2003, Journal of the American Chemical Society.

[2]  J. McMahon,et al.  Crystal engineering of the composition of pharmaceutical phases. , 2003, Chemical communications.

[3]  A. P. Lötter,et al.  Physicochemical properties and X-ray structural studies of the trigonal polymorph of carbamazepine. , 1987, Journal of pharmaceutical sciences.

[4]  G. Reck,et al.  Kristallstrukturen der Addukte Carbamazepin-Ammoniumchlorid und Carbamazepin-Ammoniumbromid sowie deren umwandlung in Carbamazepin-Dihydrat , 1991 .

[5]  G. Reck,et al.  The Order‐Disorder Structure of Carbamazepine Dihydrate: 5 H‐Dibenz [b, f] azepine‐5‐carboxamide Dihydrate, C15H12N2O · 2 H2O , 1986 .

[6]  A. Matzger,et al.  Form IV of carbamazepine. , 2002, Journal of pharmaceutical sciences.

[7]  Alan R. Kennedy,et al.  Polymorphism in 2-4-6 trinitrotoluene , 2003 .

[8]  P. York,et al.  Characterization of dihydrates prepared from carbamazepine polymorphs. , 1996, Journal of pharmaceutical sciences.

[9]  C. Gervais,et al.  Simple model designed to generate new crystal structures derived from a mother phase; application to molecular compounds. , 2002, Acta crystallographica. Section B, Structural science.

[10]  Michael B. Hursthouse,et al.  A versatile procedure for the identification, description and quantification of structural similarity in molecular crystals , 2005 .

[11]  F. Krahn,et al.  Relations between several polymorphic forms and the dihydrate of carbamazepine. , 1987, Pharmaceutica acta Helvetiae.

[12]  A. Dzyabchenko,et al.  X-ray characterization of the triclinic polymorph of carbamazepine. , 1997, Journal of pharmaceutical sciences.

[13]  J. Guyot,et al.  Polymorphic Transitions of Carbamazepine During Grinding and Compression , 1986 .

[14]  A. Matzger,et al.  Comparison of the four anhydrous polymorphs of carbamazepine and the crystal structure of form I. , 2003, Journal of pharmaceutical sciences.

[15]  N. Kaneniwa,et al.  [Hygroscopicity of carbamazepine crystalline powders]. , 1984, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

[16]  J. Rouland,et al.  Polymorphism of carbamazepine: solid-state studies on carbamazepine dihydrate. , 1991, Pharmaceutica acta Helvetiae.

[17]  D. Brooke,et al.  Heat of fusion measurement of a low melting polymorph of carbamazepine that undergoes multiple-phase changes during differential scanning calorimetry analysis. , 1991, Journal of pharmaceutical sciences.

[18]  C. Rustichelli,et al.  Solid-state study of polymorphic drugs: carbamazepine. , 2000, Journal of pharmaceutical and biomedical analysis.

[19]  A. Gavezzotti,et al.  Molecular recognition in organic crystals: directed intermolecular bonds or nonlocalized bonding? , 2005, Angewandte Chemie.

[20]  V. Nesterov,et al.  Systematic study of polymorphism in crystalline non-linear optical materials , 2003 .

[21]  R. S. Payne,et al.  Mechanical property predictions for polymorphs of sulphathiazole and carbamazepine. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[22]  F. Allen The Cambridge Structural Database: a quarter of a million crystal structures and rising. , 2002, Acta crystallographica. Section B, Structural science.

[23]  V. L. Himes,et al.  Structure of carbamazepine: 5H-dibenz[b,f]azepine-5-carboxamide , 1981 .

[24]  K. Kuroda,et al.  [Kinetics of the thermal transition of carbamazepine polymorphic forms in the solid state]. , 1984, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

[25]  Carbamazepine N,N-dimethylformamide solvate , 2005 .

[26]  László Fábián,et al.  Isostructurality in one and two dimensions: isostructurality of polymorphs. , 2004, Acta crystallographica. Section B, Structural science.

[27]  Carbamazepine furfural hemisolvate , 2005 .

[28]  Gautam R. Desiraju,et al.  Supramolecular Synthons in Crystal Engineering—A New Organic Synthesis , 1995 .

[29]  G. Bandoli,et al.  X-ray crystallographic characterization of 10,11-dihydro-5H-dibenz[b, f ]azepine-5-carboxamide , 1992 .

[30]  Peddy Vishweshwar,et al.  The predictably elusive form II of aspirin. , 2005, Journal of the American Chemical Society.

[31]  Raymond E. Davis,et al.  Patterns in Hydrogen Bonding: Functionality and Graph Set Analysis in Crystals , 1995 .

[32]  S. Itai,et al.  Physicochemical properties and bioavailability of carbamazepine polymorphs and dihydrate. , 2000, International journal of pharmaceutics.

[33]  J. Saldanha,et al.  Crystal and molecular structure of 5-carbamyl-5H-dibenzo[b,f] azepine , 1989 .

[34]  J. Reboul,et al.  5H‐Dibenz[b,f]azépinecarboxamide‐5 (carbamazépine) , 1981 .